Vident Investment Advisory, LLC Cure Vac N.V. Transaction History

Vident Investment Advisory, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 12, 2021	SELL	$49.26 - $74.5 $514,865 - $778,674	-10,452 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$56.91 - $127.53 $16,731 - $37,493	-294 Reduced 2.74%	10,452 $768,000
Q1 2021 May 14, 2021	BUY	$79.79 - $126.29 $857,423 - $1.36 Million	10,746 New	10,746 $983,000

12.2M

164K

117K

Ticker CVAC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,467,008
Market Cap $716M
Description
CureVac N.V., a clinical-stage biopharmaceutical company, focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA). It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV, which is in Phase 1 clinical trial against SARS-CoV-2; CV7202, a prophylactic mRNA-based vaccine, which ...

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Vident Investment Advisory, LLC with notifications on news.